Oncology Corporate Profile
Ionis is the leading company in RNA-targeted drug discovery and development focused on developing drugs for patients who have the highest unmet medical needs, such as those patients with severe and rare diseases. Using its proprietary antisense technology, Ionis has created a large pipeline of first-in-class or best-in-class drugs, with over three dozen drugs in development.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|AZD9150 (+ MEDI4736)||antisense drug||Diffuse large B-cell Lymphoma (DLBCL)||II||AstraZeneca|
|AZD9150 (+ MEDI4736)||antisense drug||Head & Neck cancer||II||AstraZeneca|
|AZD5312||antisense drug||Prostate cancer||II||AstraZeneca|
|apatorsen / OGX-427||antisense drug||Various cancer types||II||OncoGenex|